๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major

โœ Scribed by Casey J. Brewer; Thomas D. Coates; John C. Wood


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
365 KB
Volume
29
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Purpose

To evaluate the magnetic properties of the spleen in chronically transfused, ironโ€overloaded patients with sickle cell disease (SCD) and thalassemia major (TM) and to compare splenic iron burdens to those in the liver, heart, pancreas, and kidneys.

Materials and Methods

A retrospective analysis of 63 TM and 46 SCD patients was performed. Spleen R2 and R2* values were calculated from spinโ€echo and gradientโ€echo images collected between April 2004 and September 2007.

Results

The spleen showed a different R2โ€“R2* relationship than that previously established for the liver. At high iron concentrations (R2* > 300 Hz), spleen R2 was lower than predicted for liver. The proportion of splenic to hepatic iron content was greater in SCD patients compared with TM patients (23.8% vs. 13.8%). A weak association was found between splenic and liver ironโ€”this association was stronger in SCD patients. Little correlation was found between splenic iron and extrahepatic R2* values.

Conclusion

For spleen and liver tissue with the same R2* value, splenic R2 was significantly lower than hepatic R2, particularly for R2* > โ‰ˆ300 Hz. Splenic iron levels have little predictive value for R2* values of heart, pancreas, and kidney. J. Magn. Reson. Imaging 2009;29:357โ€“364. ยฉ 2009 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Patterns of hepatic iron distribution in
โœ Nilesh R. Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB ๐Ÿ‘ 2 views

## Abstract Patients with sickle cell disease (SCD) appear to be at lower risk of endocrinopathies and cardiac dysfunction than those with thalassemia major (TM). Circulating redox active iron is lower in these patients, possibly due to increased systemic inflammation and circulating cytokines. Hep

Morbidity and mortality in chronically t
โœ Ellen B. Fung; Paul Harmatz; Meredith Milet; Samir K. Ballas; Laura De Castro; W ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB ๐Ÿ‘ 2 views

## Abstract A natural history study was conducted in 142 Thalassemic (Thal), 199 transfused Sickle Cell Disease (Txโ€SCD, __n__ = 199), and 64 nonโ€Txโ€SCD subjects to describe the frequency of ironโ€related morbidity and mortality. Subjects recruited from 31 centers in the US, Canada or the UK were si

Cardiovascular function during rest and
โœ Braden, David S.; Covitz, Wesley; Milner, Paul F. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 595 KB

Cardiac function was measured at rest and during exercise in 9 patients with sickle-cell anemia (SS) and coexisting homozygous alpha thalassemia-2 (alpha thal-2). Results were compared with 18 sickle cell patients with normal alpha globin genes, who were matched to the study group by age, gender, an